Cardioprotection Research Both GHRP-2 and GHRP-6 have accumulated preclinical evidence for cardioprotective effects in ischemia-reperfusion injury models reduced infarct size, preserved left ventricular function, attenuated inflammatory markers
In some embodiments, a high viscosity otic formulation or device described herein provides an apparent viscosity of from about 250,000 cP to about 500,000 cP
The mechanism relates to improved blood flow and cellular regeneration
Administered at a dose of 2 mg/kg body weight per day, it alleviates senescence-induced oxidative stress and enhances the activity of antioxidants such as superoxide dismutase (SOD), catalase, glutathione peroxidase, glutathione reductase, and glucose-6-phosphate dehydrogenase (Mokra et al., 2022) (Ye et al., 2024)
vermelhido intensa
NAD IV therapy is also used to treat addiction and chronic fatigue